linvoseltamab
Regeneron
['linvoseltamab', 'mmsm', 'deliver,(-delivered),(-delivery),(-delivers),(-delivering)']
no link in the chain broken? can we give a bispecific longer term less frequently? linvoseltamab phase 2 is trying to deliver with an orr 71% and only 2 step up doses with crs in less than 50% with one patient grade 3. #asco23 #mmsm #mediq23asco 
Hematologist, Myeloma Expert, Communication Enthusiast. Professor at TGen/City of Hope and Chief Medical Officer of the International Myeloma Foundation